Your browser doesn't support javascript.
loading
Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study.
Tao, Heqing; Yu, Zhou; Dong, Yongqiang; Liu, Ligang; Peng, Liang; Chen, Xueqing.
Afiliação
  • Tao H; Department of Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Yu Z; Department of Neurology, Peking University Third Hospital, Beijing, China.
  • Dong Y; Deartment of Thyroid Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liu L; Institute of Therapeutic Innovations and Outcomes, College of Pharmacy, The Ohio State University, Columbus, OH, United States.
  • Peng L; Department of Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Chen X; Department of Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
Front Immunol ; 14: 1160312, 2023.
Article em En | MEDLINE | ID: mdl-37350960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Pró-Proteína Convertase 9 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Pró-Proteína Convertase 9 Idioma: En Ano de publicação: 2023 Tipo de documento: Article